| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 141, 31-36, Copyright © 1992 by American Society for Investigative Pathology
REGULAR ARTICLES |
V Askanas, WK Engel and RB Alvarez
University of Southern California Neuromuscular Center, Los Angeles 90017.
In 11 of 11 inclusion-body myositis (IBM) patients, including one hereditary case, vacuolated muscle fibers contained large and multiple small inclusions immunoreactive for beta-amyloid protein (beta AP). All IBM muscle biopsies had characteristic cytoplasmic tubulo-filaments (CTFs) by electron microscopy. None of 14 control muscle biopsies contained the beta AP immunoreactive (IR) inclusions characteristic of IBM. On the light microscopy level, beta AP-IR inclusions colocalized with ubiquitin immunoreactivity. By immunogold electronmicroscopy, beta AP immunoreactivity was localized to a) amorphous, poorly defined structures, b) dense floccular material, c) clusters of loosely packed amyloidlike fibrils 6-8 nm in diameter, and d) poorly defined loose fibrillar structures 6-8 nm in diameter. beta AP immunoreactive structures were often in proximity to CTFs, but CTFs themselves never contained beta AP-IR. Our study provides the first demonstration of beta AP accumulations in abnormal human muscle. This finding suggests that in addition to Alzheimer's disease, Down syndrome, and Dutch-type hereditary cerebrovascular amyloidosis, beta AP may play an important role in the pathogenesis of other diseases, including ones outside the central nervous system, for example, IBM.
This article has been cited by other articles:
 |
|
 |
|
  V. Fonte, D. R. Kipp, J. Yerg III, D. Merin, M. Forrestal, E. Wagner, C. M. Roberts, and C. D. Link Suppression of in Vivo -Amyloid Peptide Toxicity by Overexpression of the HSP-16.2 Small Chaperone Protein J. Biol. Chem., January 11, 2008; 283(2): 784 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Murphy and T. E. Golde Inclusion-body myositis and Alzheimer disease: Two sides of the same coin, or different currencies altogether? Neurology, January 24, 2006; 66(1_suppl_1): S65 - S68. [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Sugarman, T. R. Yamasaki, S. Oddo, J. C. Echegoyen, M. P. Murphy, T. E. Golde, M. Jannatipour, M. A. Leissring, and F. M. LaFerla Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle PNAS, April 30, 2002; 99(9): 6334 - 6339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Baron, D. Galimberti, L. Meda, E. Scarpini, G. Conti, F. Cogiamanian, and G. Scarlato Production of IL-6 by human myoblasts stimulated with A{beta}: Relevance in the pathogenesis of IBM Neurology, November 13, 2001; 57(9): 1561 - 1565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Broccolini, W. K. Engel, R. B. Alvarez, and V. Askanas Paired Helical Filaments of Inclusion-Body Myositis Muscle Contain RNA and Survival Motor Neuron Protein Am. J. Pathol., April 1, 2000; 156(4): 1151 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-C. Choi, G. T. Park, T.-S. Kim, I.-N. Sunwoo, P. M. Steinert, and S.-Y. Kim Sporadic Inclusion Body Myositis Correlates with Increased Expression and Cross-linking by Transglutaminases 1 and 2 J. Biol. Chem., March 17, 2000; 275(12): 8703 - 8710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Baron, D. Galimberti, L. Meda, E. Prat, E. Scarpini, G. Conti, M. Moggio, A. Prelle, and G. Scarlato Synergistic effect of {beta}-amyloid protein and interferon gamma on nitric oxide production by C2C12 muscle cells Brain, February 1, 2000; 123(2): 374 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Askanas and W. K. Engel Does Overexpression of ßAPP in Aging Muscle Have a Pathogenic Role and a Relevance to Alzheimer's Disease? : Clues from Inclusion Body Myositis, Cultured Human Muscle, and Transgenic Mice Am. J. Pathol., December 1, 1998; 153(6): 1673 - 1677. [Full Text] [PDF]
|
|
|
|
|
|
L.-W. Jin, M. G. Hearn, C. E. Ogburn, N. Dang, D. Nochlin, W. C. Ladiges, and G. M. Martin Transgenic Mice Over-Expressing the C-99 Fragment of ßPP with an {alpha}-Secretase Site Mutation Develop a Myopathy Similar to Human Inclusion Body Myositis Am. J. Pathol., December 1, 1998; 153(6): 1679 - 1686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-i. Fukuchi, D. Pham, M. Hart, L. Li, and J. R. Lindsey Amyloid-ß Deposition in Skeletal Muscle of Transgenic Mice : Possible Model of Inclusion Body Myopathy Am. J. Pathol., December 1, 1998; 153(6): 1687 - 1693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Sugarman, T. R. Yamasaki, S. Oddo, J. C. Echegoyen, M. P. Murphy, T. E. Golde, M. Jannatipour, M. A. Leissring, and F. M. LaFerla Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle PNAS, April 30, 2002; 99(9): 6334 - 6339. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
